STOCK TITAN

Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Tempus AI (NASDAQ: TEM), a technology company focused on advancing precision medicine and patient care through artificial intelligence, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. The conference is scheduled for April 7-10, 2025.

The company's Chief Financial Officer, Jim Rogers, will engage in a fireside discussion on Wednesday, April 9. The event will be accessible to viewers through a live webcast.

Tempus AI (NASDAQ: TEM), un'azienda tecnologica focalizzata sull'avanzamento della medicina di precisione e della cura dei pazienti attraverso l'intelligenza artificiale, ha annunciato la sua partecipazione alla 24ª Conferenza Virtuale Annuale sulla Salute di Needham. La conferenza si terrà dal 7 al 10 aprile 2025.

Il Direttore Finanziario dell'azienda, Jim Rogers, parteciperà a una discussione informale mercoledì 9 aprile. L'evento sarà accessibile agli spettatori tramite una diretta web.

Tempus AI (NASDAQ: TEM), una empresa de tecnología centrada en el avance de la medicina de precisión y la atención al paciente a través de la inteligencia artificial, ha anunciado su participación en la 24ª Conferencia Virtual Anual de Salud de Needham. La conferencia está programada del 7 al 10 de abril de 2025.

El Director Financiero de la empresa, Jim Rogers, participará en una discusión informal el miércoles 9 de abril. El evento será accesible para los espectadores a través de una transmisión en vivo.

템퍼스 AI (NASDAQ: TEM)는 인공지능을 통해 정밀 의학 및 환자 치료의 발전에 집중하는 기술 회사로, 제24회 니드햄 연례 가상 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 컨퍼런스는 2025년 4월 7일부터 10일까지 열릴 예정입니다.

회사의 최고재무책임자(CFO)인 Jim Rogers는 4월 9일 수요일에 비공식 대화에 참여할 예정입니다. 이 행사는 생중계를 통해 시청자들이 접근할 수 있습니다.

Tempus AI (NASDAQ: TEM), une entreprise technologique axée sur l'avancement de la médecine de précision et des soins aux patients grâce à l'intelligence artificielle, a annoncé sa participation à la 24e Conférence Virtuelle Annuelle de Santé de Needham. La conférence est prévue du 7 au 10 avril 2025.

Le directeur financier de l'entreprise, Jim Rogers, participera à une discussion informelle le mercredi 9 avril. L'événement sera accessible aux spectateurs via une diffusion en direct.

Tempus AI (NASDAQ: TEM), ein Technologieunternehmen, das sich auf die Förderung der präzisen Medizin und der Patientenversorgung durch künstliche Intelligenz konzentriert, hat seine Teilnahme an der 24. jährlichen virtuellen Gesundheitskonferenz von Needham angekündigt. Die Konferenz ist für den 7. bis 10. April 2025 geplant.

Der Finanzvorstand des Unternehmens, Jim Rogers, wird am Mittwoch, den 9. April, an einer informellen Diskussion teilnehmen. Die Veranstaltung wird für Zuschauer über einen Live-Stream zugänglich sein.

Positive
  • None.
Negative
  • None.

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the 24th Annual Needham Virtual Healthcare Conference on April 7-10, 2025.

Tempus’ Chief Financial Officer, Jim Rogers, will participate in a fireside discussion at the conference on Wednesday, April 9. A live webcast of the conversation will be available here.

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, about Tempus and Tempus’ industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements, including, but not limited to, statements regarding Tempus’ and its employee’s potential future speaking engagements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “going to,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Tempus cautions you that the foregoing may not include all of the forward-looking statements made in this press release.

You should not rely on forward-looking statements as predictions of future events. Tempus has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Tempus’ business, financial condition, results of operations and prospects. These forward-looking statements are subject to risks and uncertainties related to: Tempus’ financial performance; the ability to attract and retain customers and partners; managing Tempus’ growth and future expenses; competition and new market entrants; compliance with new laws, regulations and executive actions, including any evolving regulations in the artificial intelligence space; the ability to maintain, protect and enhance Tempus’ intellectual property; the ability to attract and retain qualified team members and key personnel; the ability to repay or refinance outstanding debt, or to access additional financing; future acquisitions, divestitures or investments; the potential adverse impact of climate change, natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled “Risk Factors” in Tempus’ Quarterly Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the Securities and Exchange Commission (“SEC”) as well as in other filings Tempus may make with the SEC in the future. In addition, any forward-looking statements contained in this press release are based on assumptions that Tempus believes to be reasonable as of this date. Tempus undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

Hanah Heintzelman

media@tempus.com

Source: Tempus AI, Inc.

FAQ

When is Tempus AI (TEM) presenting at the Needham Healthcare Conference 2025?

Tempus AI will present on Wednesday, April 9, 2025, during the 24th Annual Needham Virtual Healthcare Conference running April 7-10.

Who will represent Tempus AI (TEM) at the 2025 Needham Healthcare Conference?

Jim Rogers, Tempus AI's Chief Financial Officer, will represent the company in a fireside discussion.

How can investors watch Tempus AI's (TEM) presentation at the Needham Conference?

The presentation will be available through a live webcast.

What type of company is Tempus AI (TEM) and what is their main focus?

Tempus AI is a technology company that uses artificial intelligence to advance precision medicine and patient care.
Tempus AI

NASDAQ:TEM

TEM Rankings

TEM Latest News

TEM Stock Data

9.87B
87.53M
47.69%
34.24%
8.23%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States
CHICAGO